Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 213

1.

Bodyweight-adjusted rivaroxaban for children with venous thromboembolism (EINSTEIN-Jr): results from three multicentre, single-arm, phase 2 studies.

Monagle P, Lensing AWA, Thelen K, Martinelli I, Male C, Santamaría A, Samochatova E, Kumar R, Holzhauer S, Saracco P, Simioni P, Robertson J, Grangl G, Halton J, Connor P, Young G, Molinari AC, Nowak-Göttl U, Kenet G, Kapsa S, Willmann S, Pap AF, Becka M, Twomey T, Beyer-Westendorf J, Prins MH, Kubitza D; EINSTEIN-Jr Phase 2 Investigators.

Lancet Haematol. 2019 Aug 13. pii: S2352-3026(19)30161-9. doi: 10.1016/S2352-3026(19)30161-9. [Epub ahead of print]

PMID:
31420317
2.

Emicizumab prophylaxis among infants and toddlers with severe hemophilia A and inhibitors-a single-center cohort.

Barg AA, Avishai E, Budnik I, Levy-Mendelovich S, Barazani TB, Kenet G, Livnat T.

Pediatr Blood Cancer. 2019 Jul 26:e27886. doi: 10.1002/pbc.27886. [Epub ahead of print]

PMID:
31348595
3.

Activated protein C induces suppression and regression of choroidal neovascularization- A murine model.

Livnat T, Weinberger Y, Budnik I, Deitch I, Dahbash M, Sella R, Dardik R, Kenet G, Nisgav Y, Weinberger D.

Exp Eye Res. 2019 Sep;186:107695. doi: 10.1016/j.exer.2019.107695. Epub 2019 Jun 12.

PMID:
31201804
4.

Timing of inhibitor development in more than 1000 previously untreated patients with severe hemophilia A.

van den Berg HM, Fischer K, Carcao M, Chambost H, Kenet G, Kurnik K, Königs C, Male C, Santagostino E, Ljung R; PedNet Study Group.

Blood. 2019 Jul 18;134(3):317-320. doi: 10.1182/blood.2019000658. Epub 2019 Jun 11. No abstract available.

PMID:
31186271
5.

Clinical and Laboratory Findings in Jewish and Bedouin Patients in Southern Israel Who Were Diagnosed with Factor VII Deficiency.

Blechman S, Fruchtman Y, Perry ZH, Mazar J, Ben Harosh M, Abed A, Rozenberg N, Kenet G, Leibovitz E.

Isr Med Assoc J. 2019 May;5(21):318-321.

6.

Dehydration as a Rare Cause of Pulmonary Artery Thrombosis in a 2-Week-Old Term Neonate.

Kimhi G, Rubinshtein M, Tirosh-Wagner T, Mishaly D, Kenet G, Paret G.

J Pediatr Intensive Care. 2018 Jun;7(2):102-105. doi: 10.1055/s-0037-1607445. Epub 2017 Oct 27.

7.

[PEDIATRIC VENOUS THROMBOEMBOLISM - A COHORT STUDY IN A TERTIARY CENTER].

Gavri Beker A, Lubetsky A, Barg AA, Kenet G.

Harefuah. 2019 Mar;158(3):187-191. Hebrew.

PMID:
30916508
8.

[HEMOPHILIA - A ROYAL DISEASE IN THE HOLY LAND].

Barg AA, Dardik R, Levy-Mendelovich S, Brutman Barazani T, Bashari D, Kenet G.

Harefuah. 2019 Mar;158(3):173-175. Hebrew.

PMID:
30916504
9.

[PLATELETS FUNCTION IN A DROP OF BLOOD: FLOW CYTOMETRY ANALYSIS COMPARED TO PLATELET AGGREGATION].

Hauschner H, Katz T, Beigel R, Matetzky S, Sadeh T, Strauss Z, Kenet G, Rosenberg N.

Harefuah. 2019 Mar;158(3):168-172. Hebrew.

PMID:
30916503
10.

Mode of delivery in hemophilia: Vaginal delivery and cesarean section carry similar risks for intracranial hemorrhages and major bleeds.

Andersson NG, Chalmers EA, Kenet G, Ljung R, Mäkipernaa A, Chambost H; PedNet Haemophilia Research Foundation.

Haematologica. 2019 Feb 21. pii: haematol.2018.209619. doi: 10.3324/haematol.2018.209619. [Epub ahead of print]

11.

Recurrent stroke: the role of thrombophilia in a large international pediatric stroke population.

deVeber G, Kirkham F, Shannon K, Brandão L, Sträter R, Kenet G, Clausnizer H, Moharir M, Kausch M, Askalan R, MacGregor D, Stoll M, Torge A, Dlamini N, Ganesan V, Prengler M, Singh J, Nowak-Göttl U.

Haematologica. 2019 Aug;104(8):1676-1681. doi: 10.3324/haematol.2018.211433. Epub 2019 Jan 24.

12.

Rivaroxaban versus standard anticoagulation for acute venous thromboembolism in childhood. Design of the EINSTEIN-Jr phase III study.

Lensing AWA, Male C, Young G, Kubitza D, Kenet G, Patricia Massicotte M, Chan A, Molinari AC, Nowak-Goettl U, Pap ÁF, Adalbo I, Smith WT, Mason A, Thelen K, Berkowitz SD, Crowther M, Schmidt S, Price V, Prins MH, Monagle P.

Thromb J. 2018 Dec 21;16:34. doi: 10.1186/s12959-018-0188-y. eCollection 2018.

13.

Low Concentrations of Recombinant Factor VIIa May Improve the Impaired Thrombin Generation of Glanzmann Thrombasthenia Patients.

Levy-Mendelovich S, Levy T, Budnik I, Barg AA, Rosenberg N, Seligsohn U, Kenet G, Livnat T.

Thromb Haemost. 2019 Jan;119(1):117-127. doi: 10.1055/s-0038-1676348. Epub 2018 Dec 31.

PMID:
30597506
14.

Health-related quality of life in paediatric haemophilia B patients treated with rIX-FP.

von Mackensen S, Shah J, Seifert W, Kenet G.

Haemophilia. 2019 Jan;25(1):45-53. doi: 10.1111/hae.13624. Epub 2018 Nov 14.

PMID:
30427091
15.

Clinical presentation and therapeutic management of venous thrombosis in young children: a retrospective analysis.

Chan A, Lensing AWA, Kubitza D, Brown G, Elorza D, Ybarra M, Halton J, Grunt S, Kenet G, Bonnet D, Santamaria A, Saracco P, Biss T, Climent F, Connor P, Palumbo J, Thelen K, Smith WT, Mason A, Adalbo I, Berkowitz SD, Hurst E, van Kesteren J, Young G, Monagle P.

Thromb J. 2018 Nov 1;16:29. doi: 10.1186/s12959-018-0182-4. eCollection 2018.

16.

A Genetic Origin? Purpura Fulminans.

Avnery O, Kenet G, Ellis MH.

Am J Med. 2019 Mar;132(3):327-328. doi: 10.1016/j.amjmed.2018.10.003. Epub 2018 Oct 24. No abstract available.

PMID:
30367859
17.

A Proposed Role of Surfactant in Platelet Function and Treatment of Pulmonary Hemorrhage in Preterm and Term Infants.

Sadeh-Vered T, Rosenberg N, Morag I, Berg AA, Kenet G, Strauss T.

Acta Haematol. 2018;140(4):215-220. doi: 10.1159/000493082. Epub 2018 Oct 19.

PMID:
30343298
18.

Alternative treatment options for pediatric hemophilia B patients with high-responding inhibitors: A thrombin generation-guided study.

Barg AA, Levy-Mendelovich S, Avishai E, Dardik R, Misgav M, Kenet G, Livnat T.

Pediatr Blood Cancer. 2018 Dec;65(12):e27381. doi: 10.1002/pbc.27381. Epub 2018 Sep 19.

PMID:
30230231
19.

From thrombasthenia to next generation thrombocytopenia: Neonatal alloimmune thrombocytopenia induced by maternal Glanzmann thrombasthenia.

Barg AA, Hauschner H, Luboshitz J, Livnat T, Straus T, Levy-Mendelovich S, Lubetsky A, Rosenberg N, Kenet G.

Pediatr Blood Cancer. 2018 Dec;65(12):e27376. doi: 10.1002/pbc.27376. Epub 2018 Sep 14.

PMID:
30216638
20.

A novel approach using ancillary tests to guide treatment of Glanzmann thrombasthenia patients undergoing surgical procedures.

Barg AA, Hauschner H, Misgav M, Lubetsky A, Levy-Mendelowitz S, Livnat T, Avishai E, Rosenberg N, Kenet G.

Blood Cells Mol Dis. 2018 Sep;72:44-48. doi: 10.1016/j.bcmd.2018.07.003. Epub 2018 Aug 2.

PMID:
30078718
21.

Hemostasis in the Very Young.

Kenet G, Barg AA, Nowak-Göttl U.

Semin Thromb Hemost. 2018 Oct;44(7):617-623. doi: 10.1055/s-0038-1660852. Epub 2018 Jun 18. Review.

PMID:
29913536
22.

Thrombosis in pediatric patients with leukemia.

Levy-Mendelovich S, Barg AA, Kenet G.

Thromb Res. 2018 Apr;164 Suppl 1:S94-S97. doi: 10.1016/j.thromres.2018.01.019. Review.

PMID:
29703491
23.

In vitro characterization of MOD-5014, a novel long-acting carboxy-terminal peptide (CTP)-modified activated FVII.

Bar-Ilan A, Livnat T, Hoffmann M, Binder L, Zakar M, Guy R, Felikman Y, Moschcovich L, Shenkman B, Monroe D, Hershkovitz O, Kenet G, Hart G.

Haemophilia. 2018 May;24(3):477-486. doi: 10.1111/hae.13428. Epub 2018 Mar 14.

PMID:
29537116
24.

Thrombophilia testing in children: What and when should be tested?

Nowak-Göttl U, van Ommen H, Kenet G.

Thromb Res. 2018 Apr;164:75-78. doi: 10.1016/j.thromres.2018.02.136. Epub 2018 Feb 21. Review.

PMID:
29518638
25.

Treatment tailoring for factor V deficient patients and perioperative management using global hemostatic coagulation assays.

Levy-Mendelovich S, Barg AA, Rosenberg N, Avishai E, Luboshitz J, Misgav M, Kenet G, Livnat T.

Blood Cells Mol Dis. 2018 Jul;71:5-10. doi: 10.1016/j.bcmd.2018.01.002. Epub 2018 Apr 5.

PMID:
29402705
26.

Possible involvement of NETosis in inflammatory processes in the eye: Evidence from a small cohort of patients.

Barliya T, Dardik R, Nisgav Y, Dachbash M, Gaton D, Kenet G, Ehrlich R, Weinberger D, Livnat T.

Mol Vis. 2017 Dec 13;23:922-932. eCollection 2017.

27.

Vaccinations are not associated with inhibitor development in boys with severe haemophilia A.

Platokouki H, Fischer K, Gouw SC, Rafowicz A, Carcao M, Kenet G, Liesner R, Kurnik K, Rivard GE, van den Berg HM.

Haemophilia. 2018 Mar;24(2):283-290. doi: 10.1111/hae.13387. Epub 2017 Dec 15.

PMID:
29243367
28.

Inhibitors in Hemophilia: Treatment Challenges and Novel Options.

Barg AA, Livnat T, Kenet G.

Semin Thromb Hemost. 2018 Sep;44(6):544-550. doi: 10.1055/s-0037-1612626. Epub 2017 Dec 12. Review.

PMID:
29232720
29.

Risk Factors for the Progression from Low to High Titres in 260 Children with Severe Haemophilia A and Newly Developed Inhibitors.

Mancuso ME, Fischer K, Santagostino E, Oldenburg J, Platokouki H, Königs C, Escuriola-Ettingshausen C, Rivard GE, Cid AR, Carcao M, Ljung R, Petrini P, Altisent C, Kenet G, Liesner R, Kurnik K, Auerswald G, Chambost H, Mäkipernaa A, Molinari AC, Williams M, van den Berg HM; European Pediatric Network for Haemophilia Management (PedNet) the REMAIN (REal life MAnagement of children with INhibitors) Study Group.

Thromb Haemost. 2017 Dec;117(12):2274-2282. doi: 10.1160/TH17-01-0059. Epub 2017 Dec 6.

PMID:
29212115
30.

Heparin-induced thrombocytopenia complicating children after the Fontan procedure: Single-center experience and review of the literature.

Pollak U, Mishaly D, Kenet G, Vardi A.

Congenit Heart Dis. 2018 Jan;13(1):16-25. doi: 10.1111/chd.12557. Epub 2017 Nov 27. Review.

PMID:
29181882
31.

Editorial for special pediatric hemostasis issue BCMD.

Kenet G, Nowak-Göttl U.

Blood Cells Mol Dis. 2017 Sep;67:1. doi: 10.1016/j.bcmd.2017.09.010. No abstract available.

PMID:
29113682
32.

Intracranial haemorrhage in children and adolescents with severe haemophilia A or B - the impact of prophylactic treatment.

Andersson NG, Auerswald G, Barnes C, Carcao M, Dunn AL, Fijnvandraat K, Hoffmann M, Kavakli K, Kenet G, Kobelt R, Kurnik K, Liesner R, Mäkipernaa A, Manco-Johnson MJ, Mancuso ME, Molinari AC, Nolan B, Perez Garrido R, Petrini P, Platokouki HE, Shapiro AD, Wu R, Ljung R.

Br J Haematol. 2017 Oct;179(2):298-307. doi: 10.1111/bjh.14844. Epub 2017 Jul 12.

PMID:
28699675
33.

Combination of hemostatic therapies for treatment of patients with hemophilia A and inhibitors.

Livnat T, Budnik I, Levy-Mendelovich S, Avishai E, Misgav M, Barg AA, Lubetsky A, Brutman-Barazani T, Kenet G.

Blood Cells Mol Dis. 2017 Jul;66:1-5. doi: 10.1016/j.bcmd.2017.06.005. Epub 2017 Jun 27.

PMID:
28689155
34.

Estimating the potential cost of a high dose immune tolerance induction (ITI) therapy relative to the cost of a combined therapy of a low dose ITI therapy with bypassing agent prophylaxis.

Kenet G, Oladapo A, Epstein JD, Thompson C, Novack A, Nugent DJ.

Haemophilia. 2017 Sep;23(5):e394-e402. doi: 10.1111/hae.13294. Epub 2017 Jun 22.

PMID:
28641362
35.

Correlation between Interleukin-6 and Thrombin-Antithrombin III Complex Levels in Retinal Diseases.

Ehrlich R, Zahavi A, Axer-Siegel R, Budnik I, Dreznik A, Dahbash M, Nisgav Y, Megiddo E, Kenet G, Weinberger D, Livnat T.

Curr Eye Res. 2017 Sep;42(9):1269-1272. doi: 10.1080/02713683.2017.1313432. Epub 2017 Jun 20.

PMID:
28632410
36.

Quantification of specific T and B cells immunological markers in children with chronic and transient ITP.

Levy-Mendelovich S, Lev A, Aviner S, Rosenberg N, Kaplinsky C, Sharon N, Miskin H, Dvir A, Kenet G, Schushan IE, Somech R.

Pediatr Blood Cancer. 2017 Dec;64(12). doi: 10.1002/pbc.26646. Epub 2017 May 22.

PMID:
28544224
37.

The hemostatic efficacy of chitosan-pads in hemodialysis patients with significant bleeding tendency.

Misgav M, Lubetszki A, Brutman-Barazani T, Martinowitz U, Kenet G.

J Vasc Access. 2017 May 15;18(3):220-224. doi: 10.5301/jva.5000707. Epub 2017 Apr 28.

PMID:
28478622
38.

European evidence-based recommendations for diagnosis and treatment of paediatric antiphospholipid syndrome: the SHARE initiative.

Groot N, de Graeff N, Avcin T, Bader-Meunier B, Dolezalova P, Feldman B, Kenet G, Koné-Paut I, Lahdenne P, Marks SD, McCann L, Pilkington CA, Ravelli A, van Royen-Kerkhof A, Uziel Y, Vastert SJ, Wulffraat NM, Ozen S, Brogan P, Kamphuis S, Beresford MW.

Ann Rheum Dis. 2017 Oct;76(10):1637-1641. doi: 10.1136/annrheumdis-2016-211001. Epub 2017 May 4. Review.

PMID:
28473426
39.

Thrombin generation as a predictor of thromboembolic events in multiple myeloma patients.

Leiba M, Malkiel S, Budnik I, Rozic G, Avigdor A, Duek A, Nagler A, Kenet G, Livnat T.

Blood Cells Mol Dis. 2017 Jun;65:1-7. doi: 10.1016/j.bcmd.2017.03.010. Epub 2017 Mar 25.

PMID:
28365523
40.

An extra X does not prevent acquired hemophilia - Pregnancy-associated acquired hemophilia A.

Barg AA, Livnat T, Kenet G.

Thromb Res. 2017 Mar;151 Suppl 1:S82-S85. doi: 10.1016/S0049-3848(17)30074-9. Review.

PMID:
28262242
41.

Rare bleeding disorders-old diseases in the era of novel options for therapy.

Livnat T, Barg AA, Levy-Mendelovich S, Kenet G.

Blood Cells Mol Dis. 2017 Sep;67:63-68. doi: 10.1016/j.bcmd.2017.02.003. Epub 2017 Feb 14. Review.

PMID:
28222949
42.

A man-made disease: Fetal neonatal alloimmune thrombocytopenia due to incompatibility between oocyte donor and gestational mother.

Barg AA, Ifrah AD, Strauss T, Simchen MJ, Orvieto R, Rosenberg N, Kenet G.

Pediatr Blood Cancer. 2017 Aug;64(8). doi: 10.1002/pbc.26447. Epub 2017 Jan 18.

PMID:
28097780
43.

Activity of Von Willebrand factor and levels of VWF-cleaving protease (ADAMTS13) in preterm and full term neonates.

Strauss T, Elisha N, Ravid B, Rosenberg N, Lubetsky A, Levy-Mendelovich S, Morag I, Nowak Göttl U, Kenet G.

Blood Cells Mol Dis. 2017 Sep;67:14-17. doi: 10.1016/j.bcmd.2016.12.013. Epub 2016 Dec 29.

PMID:
28087247
44.

Primary prophylaxis for children with severe congenital factor VII deficiency - Clinical and laboratory assessment.

Kuperman AA, Barg AA, Fruchtman Y, Shaoul E, Rosenberg N, Kenet G, Livnat T.

Blood Cells Mol Dis. 2017 Sep;67:86-90. doi: 10.1016/j.bcmd.2016.12.008. Epub 2016 Dec 19.

PMID:
28038846
45.

Developmental hemostasis: A lifespan from neonates and pregnancy to the young and elderly adult in a European white population.

Nowak-Göttl U, Limperger V, Kenet G, Degenhardt F, Arlt R, Domschikowski J, Clausnizer H, Liebsch J, Junker R, Steppat D.

Blood Cells Mol Dis. 2017 Sep;67:2-13. doi: 10.1016/j.bcmd.2016.11.012. Epub 2016 Dec 5.

PMID:
28017497
46.

Risk factors for symptomatic venous and arterial thromboembolism in newborns, children and adolescents - What did we learn within the last 20years?

Kenet G, Limperger V, Shneyder M, Nowak-Göttl U.

Blood Cells Mol Dis. 2017 Sep;67:18-22. doi: 10.1016/j.bcmd.2016.12.003. Epub 2016 Dec 14. Review.

PMID:
28010922
47.

Quantitation of bleeding symptoms in a national registry of patients with inherited platelet disorders.

Revel-Vilk S, Richter C, Ben-Ami T, Yacobovich J, Aviner S, Ben-Barak A, Kuperman AA, Ben-Barak S, Kaplinsky C, Miskin H, Tamary H, Kenet G.

Blood Cells Mol Dis. 2017 Sep;67:59-62. doi: 10.1016/j.bcmd.2016.11.013. Epub 2016 Dec 18.

PMID:
27998672
48.

Impact of high risk thrombophilia status on recurrence among children and adults with VTE: An observational multicenter cohort study.

Brüwer G, Limperger V, Kenet G, Klostermeier UC, Shneyder M, Degenhardt F, Finckh U, Heller C, Holzhauer S, Trappe R, Kentouche K, Knoefler R, Kurnik K, Krümpel A, Lauten M, Manner D, Mesters R, Junker R, Nowak-Göttl U.

Blood Cells Mol Dis. 2016 Nov;62:24-31. doi: 10.1016/j.bcmd.2016.10.024. Epub 2016 Nov 5.

PMID:
27838551
49.

Impact of gender on safety and efficacy of Rivaroxaban in adolescents & young adults with venous thromboembolism.

Krause M, Henningsen A, Torge A, Juhl D, Junker R, Kenet G, Kowalski D, Limperger V, Mesters R, Anonymous, Rocke A, Shneyder M, Clausnizer H, Schiesewitz H, Nowak-Göttl U.

Thromb Res. 2016 Dec;148:145-151. doi: 10.1016/j.thromres.2016.09.007. Epub 2016 Sep 13. No abstract available.

PMID:
27687905
50.

Long-acting recombinant fusion protein linking coagulation factor IX with albumin (rIX-FP) in children. Results of a phase 3 trial.

Kenet G, Chambost H, Male C, Lambert T, Halimeh S, Chernova T, Mancuso ME, Curtin J, Voigt C, Li Y, Jacobs I, Santagostino E; PROLONG-9FP Investigator Study Group.

Thromb Haemost. 2016 Sep 27;116(4):659-68. doi: 10.1160/TH16-03-0179. Epub 2016 Sep 1.

Supplemental Content

Support Center